Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Caraco Pharma to Cut Work Force in Half

By Pharmaceutical Processing | July 7, 2009

DETROIT (AP) — Caraco Pharmaceutical Laboratories Ltd., which recalled its heart drug digoxin earlier this year, is cutting its work force in half to reduce expenses. Caraco said it is in talks with the FDA about resuming some or all of its manufacturing, which was stopped after recalls and a seizure of its products by federal marshals. The company had 667 workers as of March 31. The company has issued several product recalls this year, starting in January. It recalled some lots of the heart drug digoxin in March, and in April voluntarily recalled drugs made in a Detroit facility. In June, U.S. Marshals seized products and ingredients made at Caraco’s plants in Detroit, Farmington Hills, and Wixom, Mich., at the request of the FDA. The agency said the company’s manufacturing processes did not meet FDA standards. Caraco had recalled 0.125 mg and 0.25 mg digoxin tablets on March 31 because some of the tablets were the wrong size, which could have caused an overdose. Caraco also announced that JPMorgan Chase says Caraco’s $10 million line of credit is not available until the company resolves its issues with the FDA. Caraco said the move doesn’t have any significant effect on its financial position.

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE